PRESS RELEASE
4 August 2020

Please Join Us For An Upcoming CLE Webinar, “Preparing For The Inevitable: FCA Investigations In A Post-COVID World”

RS
Reed Smith

Contributor

The CARES Act funding was a lifeline for many health care organizations and life sciences companies, but came with significant attached strings.
United States
To print this article, all you need is to be registered or login on Mondaq.com.

The CARES Act funding was a lifeline for many health care organizations and life sciences companies, but came with significant attached strings. Related fraud charges are already making headlines and bring with them the serious risk of False Claims Act litigation, which can have bet-the-company implications for companies.

Please join us this Wednesday, August 5 at 2 p.m. ET for a CLE webinar on "Preparing for the inevitable: FCA investigations in a post-COVID world" presented by our Life Sciences Health Industry Group partners Rick Robinson and Sarah Cummings.

This webinar will help companies understand the False Claims Act enforcement risks stemming from CARES Act funds, along with other enforcement risks stemming from COVID-related developments. Rick and Sarah will also provide an overview of recent key False Claims Act enforcement developments pre-COVID to set the stage for the discussion.

For more information, or to register, please click here.

This program is presumptively approved for 1.0 CLE credit in California, Connecticut, Illinois, New Jersey, New York, Pennsylvania, Texas and West Virginia. Applications for CLE credit will be filed in Delaware, Florida, Ohio, and Virginia. Attendees who are licensed in other jurisdictions will receive a uniform certificate of attendance but Reed Smith only provides credit for the states listed.

PRESS RELEASE
4 August 2020

Please Join Us For An Upcoming CLE Webinar, “Preparing For The Inevitable: FCA Investigations In A Post-COVID World”

United States

Contributor

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More